Readers with an interest in how we got to today’s clinical trials processes for evaluating new drugs for the treatment of prostate cancer and other diseases might be surprised by what’s in an article in this week’s New England Journal of Medicine. … READ MORE …
Filed under: Drugs in development | Tagged: development, drug, marketing, regulation, trials | 2 Comments »
Many readers may be interested in an article by Gina Kolata in Saturday’s New York Times on the rapid uptake of robot-assisted laparoscopic prostatectomy (RALP) for the first-line treatment prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: marketing, RALP, robot-assisted laparoscopic prostatectomy | Comments Off on The marketing of RALP: 2002 to 2010
THE "NEW" PROSTATE CANCER INFOLINK 